GemCap Biotech ApS: Financial statements 2021
CVR: 38189174
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
GemCap Biotech ApS (CVR 38189174) has filed annual accounts for 2021. In 2021, the company reported a net result of EUR 0 compared with EUR 0 the year before. Equity in the 2021 report amounted to EUR 6,750. The solvency ratio was 100%.
- Profit/Loss
- EUR 0
- Equity
- EUR 6,750
- Total Assets
- EUR 6,750
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | 0 EUR | 7 t. EUR | - |
| 2020 | - | - | 0 EUR | 7 t. EUR | - |
| 2019 | - | - | 0 EUR | 7 t. EUR | - |
| 2018 | - | - | 0 EUR | 7 t. EUR | - |
Official annual report
Find more companies like GemCap Biotech ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
GemCap Biotech ApS has published its annual report for 2020. The net result was DKK 0.
About GemCap Biotech ApS
GemCap Biotech ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2016. The company has been dissolved on 24 March 2024. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a net result of EUR 0 compared with EUR 0 the year before. Equity in the 2023 report amounted to EUR 27,000.